Publication
Preclinical evaluation of novel FGFR2-targeting peptide probes for PET imaging and intraoperative navigation in gastric Cancer.
Xiaoqiang Yang, Jing Zhao, Kaili Xie, Wei Fan, Wanqi Chen, Xiaofei Zhang
Bioorganic chemistrySep 15, 2026PMID 42401168doi:10.1016/j.bioorg.2026.110174 Journal ArticlepubmedProvenance
- Source
- PubMed
- Retrieved
- Sep 19, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-PUBMED-20260919-000001
Abstract
Abstract (excerpt)
Only the opening of the abstract is shown; abstract text may carry publisher copyright.
Fibroblast growth factor receptor 2 (FGFR2) is extensively acknowledged as a clinically significant biomarker across various cancer types, exhibiting elevated expression levels in numerous malignancies, with particularly pronounced overexpression in gastric cancer. In the present study, we refined…
Read on PubMedLinked entities
Linked entities (1)
How each link was made (MeSH, dictionary, registry reference, curation…) and whether it has been validated. Candidate links are not counted in entity statistics.
Candidate 1
- cancerMalignant Gastric Neoplasmdictionary0.60
Curated evidence
Evidence citing this paper (0)
Data not yet available
No curated evidence item cites this publication.